Ultra-efficient multiple cross displacement amplification-lateral flow biosensor (MCDA-LFB) for serogroup...

Area of Science:

• Microbiology
• Molecular Biology
• Biosensor Technology

Background:

• Meningococcal disease, caused by Neisseria meningitidis, is a significant global health threat.
• Serogroups A, B, C, and W135 are the primary causative agents of invasive meningococcal disease.
• Accurate and rapid detection and differentiation of these serogroups are crucial for effective disease control.

Purpose of the Study:

• To develop and validate a novel Multiple Cross Displacement Amplification-Lateral Flow Biosensor (MCDA-LFB) assay.
• To enable sensitive and specific detection and subtyping of four major Neisseria meningitidis serogroups (A, B, C, W135).
• To provide a rapid molecular diagnostic tool for meningococcal disease.

Main Methods:

• Development of MCDA-LFB assays targeting specific genes (ctrA, sacB, siaD, synG) for each serogroup.
• Utilizing a double antibody sandwich principle for detecting FITC and biotin-labeled amplicons.
• Assessing assay sensitivity using genomic DNA and spiked cerebrospinal fluid (CSF) specimens.
• Validating specificity with Neisseria meningitidis type strains and clinical isolates.

Main Results:

• The MCDA-LFB assays demonstrated high sensitivity, with detection limits as low as 10 fg genomic DNA or 5.5 Colony Forming Units (CFUs) in spiked CSF.
• Sensitivity was 100 to 1000-fold higher than conventional PCR.
• Assays exhibited excellent specificity, with no cross-reactions observed among tested strains.
• The entire testing procedure was completed within 1 hour.

Conclusions:

• The developed Neisseria meningitidis and serogroup-specific MCDA-LFB assays are simple, rapid, and efficient.
• These assays offer a valuable molecular method for the diagnosis and surveillance of meningococcal disease.
• The technology is particularly suitable for resource-limited regions and situations where specimen culture is challenging or fails.